Sire Bioscience Inc. (SIRE) (CSE:SIRE, FRA:BR1B,OTCX:BLLXF), a Health Canada hemp license holder with a goal of becoming a vertically integrated CPG leader in the CBD marketplace, is pleased to announce the Company has commenced discussions, as well as entered into a non-binding Cannabidiol (“CBD”) Commercialization and Consulting Letter of Intent (“LOI”), dated September 24, 2019, with Fusion Nutrition Inc. (“FUSION”),  a nationally branded supplement manufacturer.

The 20 year old Canadian-based, leading supplement company has national distribution and currently hosts up to 9 brands, including PURPLE-K, the king of creatine. Fusion Nutrition has some of the fastest-growing supplements in Canada and numerous category leaders sold in Canada’s top five sports nutrition retailers. To add more depth to their lineup, Fusion is also currently ramping up the release of its protein powder called PROZILLA. You can learn more about Fusion Nutrition at


Ryan Herniman, Fusion President, comments, “Within the sports nutrition space a more obvious synergy has never presented itself. With our combined experience in the world of CPG’s we’ll not only be able to develop world-class offerings but we’ll be able to help a lot of people and that motivates us tremendously. It’s an exciting new time in sports nutrition and we’re thrilled to be working with Sire on this initiative.”

The sports nutrition market is vast – covering a wide range of categories such as protein powders, protein bars, branched-chain amino acids (BCAAs), pre-workout blends, nitric oxide boosters, and creatine supplements. Largely driven by the Millennial demographic, the market shows no signs of slowing down. According to Allied Market Research, the global sports nutrition market is expected to reach $44 billion by 2021.

Meanwhile, cannabis industry analyst, Brightfield Group, advises the hemp-CBD market alone could hit $22 billion by 2022. Brightfield Group also comments that CBD trials have been found to be particularly effective at treating conditions of pain, sleep disturbance, spasticity, and seizures, as well as decreasing one’s dependency on other drugs such as opioids.

Jeff Zanini, Sire CEO, comments, “The union of these two massive industries will create a business-related sonic boom. Sports nutrition combined with CBD is a winning formula. It’s also aligned with everything that Sire is all about – such as having an early-mover advantage to win the CPG race, staying on the fastest track to revenue and profits, and elevating the consciousness of humanity, all while sustainably increasing shareholder value.  This is a pure winner and we couldn’t be more excited.”

The non-binding LOI contemplates the branded and private label creation and supply of Sire’s House of Brands portfolio of CBD-infused CPG products.

Terms of the LOI include but are not limited to:

  • Scientific study and analysis of the CBD/sports nutrition industry to ensure best-in-class deliverable methods.
  • Regulatory analysis to ensure compliance with regulatory bodies in Canada, supporting fastest “go-to-market” strategy.
  • Exclusivity of arrangement between SIRE and FUSION.
  • Exchange of Branding, Licensing and Intellectual Property.

There is no guarantee the transaction proposed will be completed.  Sire will provide further disclosure by way of press release and updates as such additional information becomes available.

About Sire Bioscience
Sire’s principal business activity is to engage in the investment, production of and sale of hemp for CBD extraction. Sire has its wholly-owned, state-of-the-art facility in Leamington, Ontario – a preeminent locale for hemp cultivation in Canada. The land parcel includes 50 acres of prime horticultural land, with a 160,000 sq. ft facility of combined greenhouse and indoor space. Our goal is to become a vertically integrated CPG life science company with our “House of Brands” offering.  Sire is headquartered in Toronto, Ontario and is backed by a group of successful entrepreneurs who have extensive experience in the areas of manufacturing, logistics, and renewable energy.


Sire Bioscience Inc.
Jeff Zanini
T: 416-262-0871

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Forward-looking Information Cautionary Statement
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release. Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

Click here to connect with Sire Bioscience (CSE:SIRE) for an Investor Presentation.



Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

One major cannabis analyst gave her top stock pick this week as industry attention continues to converge on the path ahead for the US market.

Also this week, the CEO of Aphria (NASDAQ:APHA,TSX:APHA) gave an update on a critical merger and spoke about who holds the edge in the US in terms of American and Canadian cannabis operators.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 First Quarter Earnings Conference Call on Friday, May 7, 2021 at 8:30 a.m. EDT. Cronos Group’s senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

A live audio webcast of the earnings call will be available on the Company’s website at . The webcast of the call will be archived for replay on the Company’s website.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

A report just released in early April confirms that the cannabis beverage sector is thriving. According to this report from industry stalwart, Marijuana Business Daily while sales for vapes, pre-rolls and flower were lackluster, cannabis beverages shined:

Keep reading... Show less

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event:

Keep reading... Show less